Patents
Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
05/2000
05/02/2000US6057326 Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors
05/02/2000US6057305 Antiretroviral enantiomeric nucleotide analogs
05/02/2000CA2004784C Anti-aids virus agent 2-amino-6-chlorpurine-9-.beta.-2,'3'-dideoxyribofuranoside
04/2000
04/27/2000WO2000023457A1 Adenine derivatives
04/27/2000WO2000023447A1 Adenosine analogues having antihypertensive, cardioprotective, anti-ischemic antilipolytic properties
04/26/2000EP0994877A1 Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
04/26/2000EP0994860A1 Aryl-and arylamino-substituted heterocycles as corticotropin releasing hormone antagonists
04/26/2000CN1251296A Use of anticancer material and production method of said anti-cancer material
04/25/2000US6054568 Polymer of nucleobases capable of watson/crick basepairing connected together by linkers and having terminating groups; for nucleic acid analogs which may be used in annealing, ligation, sequencing, cleavage and primer extension reactions
04/25/2000US6054441 Antiinflammatory agents; treatment of bacterial, viral or fungal infections; autoimmune diseases
04/25/2000CA2015671C Phosphonomethoxytetrahydrofuranyl-purine/pyrimidine derivatives
04/19/2000EP0586520B1 Backbone modified oligonucleotide analogs
04/19/2000CN1251039A Antitussive compositions
04/19/2000CN1051550C 4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopntene-1-methanol succinate as antiviral agent
04/18/2000US6051709 Process for the diastereoselective synthesis of nucleoside analogues
04/18/2000US6051579 Viricide for herpes virus
04/13/2000WO2000020556A2 Zinc finger-reactive antimicrobial compounds
04/13/2000WO2000020421A2 TRICYCLIC Δ3-PIPERIDINES AS α2-ANTAGONISTS
04/13/2000WO2000020393A1 Substituted 1,3-diaryl-2-pyridine-2-yl-3-(pyridine-2-ylamino)-propanol derivatives, methods for their production, pharmaceutical compositions containing the same and their use
04/13/2000DE19845406A1 Substituierte 1,3-Diaryl-2-pyridin-2-yl-3-(pyridin-2-ylamino)- propanolderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung Substituted 1,3-diaryl-2-pyridin-2-yl-3- (pyridin-2-ylamino) - propanol derivatives, process for their preparation, pharmaceutical compositions containing them and their use
04/13/2000CA2345212A1 Zinc finger-reactive antimicrobial compounds
04/12/2000CN1250449A Novel Z-valacyclovir crystals
04/11/2000CA2120725C Chemical compounds
04/06/2000WO2000018409A1 Use of certain drugs for treating nerve root injury
04/06/2000CA2714449A1 Use of certain drugs for treating nerve root injury
04/05/2000EP0989857A1 Novel therapeutic agents that modulate enzymatic processes
04/05/2000CN1249752A Annulated azole derivs. useful as microbicidal agents
04/05/2000CN1051084C Preparation of N-9 substd. guanine compounds
04/05/2000CN1051083C Novel substd. puriny derivs. with immunomodulating activity
04/04/2000US6046306 PNA synthesis using an amino protecting group which is labile to weak acids
03/2000
03/30/2000WO2000017190A2 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
03/30/2000WO2000016755A2 Antiviral combinations of lamivudine and adefovir
03/30/2000CA2344224A1 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
03/30/2000CA2344172A1 Antiviral combinations
03/29/2000EP0988304A1 Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (hbv)
03/28/2000US6043364 Regiospecific process for synthesis of acyclic nucleosides
03/28/2000US6043250 Treating or preventing inflammatory diseases
03/28/2000CA2180978C Pyrrolidine-containing monomers and oligomers
03/28/2000CA2011238C Pharmaceutical treatment
03/22/2000EP0986561A1 Compounds for inhibition of ceramide-mediated signal transduction
03/22/2000CN1247866A Process for preparation of guanine
03/22/2000CN1050603C Prepn. of intermediate product used in process for diastereoselective synthesis of nucleosides
03/21/2000US6040447 Reacting a halogenated amino pyrimidine compound with acid anhydride or acid halide to form an intermediate, transforming the 6-halo group of the intermediate to an amine by displacement with ammonia, cyclizing with a base
03/21/2000US6040446 Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivative
03/21/2000US6040445 Acyclovir dihydrate sodium salt and the preparation thereof
03/16/2000WO1999064047A9 Novel antiviral compounds
03/16/2000WO1999063929A9 Multibinding inhibitors of microsomal triglyceride transferase protein
03/15/2000EP0619805B1 5-(hetero- or carbocyclylamino)-indole derivatives, their preparation and their use as 5-ht1 agonists
03/14/2000US6037470 Purine compounds having PDE IV inhibitory activity and methods of synthesis
03/14/2000US6037347 Comprising a compound which has an acetylcholinesterase-inhibitory action or exhibits muscarinergic action and a compound which increases the endogenous extracellular adenosine level
03/09/2000WO2000012077A1 Potassium channel inhibitors and method
03/09/2000WO2000012076A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
03/09/2000WO2000012074A2 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
03/09/2000CA2342251A1 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
03/09/2000CA2339189A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
03/08/2000EP0984014A2 Process for the preparation or guanine
03/08/2000EP0983290A1 Method for producing polymers having nucleo-bases as side-groups
03/08/2000EP0983271A1 Carbocyclic nucleoside hemisulfate and its use in treating viral infections
03/08/2000EP0983222A1 Pharmaceutical agents for the treatment of cerebral amyloidosis
03/08/2000CN1246477A Preparation of N-9 substituted guanine compound
03/08/2000CN1246475A Corticotropin release factors antagonistic agent
03/08/2000CN1050122C Benzimidazoles, pharmaceutical compositions containing these compounds and process for preparing them
03/07/2000US6034087 Nucleoside derivatives and process for preparing thereof
03/02/2000WO2000011002A1 9-dialkylamino purinone derivatives
03/02/2000WO1999064054A9 Multibinding inhibitors of topoisomerase
03/02/2000WO1999063937A3 Multivalent macrolide antibiotics
03/02/2000DE19839013A1 Verfahren zur Hestellung von Guanin Process for the operations department of guanine
03/02/2000DE19838300A1 9-Dialkylaminopurinon-derivate 9-Dialkylaminopurinon derivatives
03/01/2000CN1246124A 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
03/01/2000CN1049893C Valaciclovic hydrochloride and its preparing method, and its use
02/2000
02/29/2000CA2002648C 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivatives
02/24/2000WO2000009507A1 Phenyl yanthine derivatives
02/24/2000WO2000009494A1 Method of manufacture of 1,3-oxathiolane nucleosides
02/24/2000CA2714085A1 Method of manufacture of 1,3-oxathiolane nucleosides
02/24/2000CA2340350A1 Phenyl yanthine derivatives
02/23/2000CN1049659C Corticotropin releasing factor antagonists
02/22/2000US6028076 Purine derivative
02/22/2000CA2002834C Cycloalkyl xanthines
02/22/2000CA1340909C Purine derivatives and use thereof in therapy
02/17/2000WO2000008041A1 Structural analogs of amine bases and nucleosides
02/17/2000WO2000008025A1 Synthesis of acyclic nucleoside derivatives
02/17/2000WO1999051604A3 Process for the production of purine derivatives
02/17/2000WO1999003858A9 Novel purine derivatives and medicinal use thereof
02/16/2000EP0979082A1 Antiviral combinations containing the carbocyclic nucleoside 1592u89
02/16/2000EP0979077A1 Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders
02/15/2000US6025361 Effective pde iv inhibitors, asthma
02/15/2000US6025360 Use of theophylline for the manufacture of a medicament for the treatment of asthma
02/10/2000WO2000006573A1 Antiviral alkyl substituted purine derivatives and their preparation
02/10/2000WO2000006569A1 Substituted pyrazole derivatives condensed with six-membered heterocyclic rings
02/10/2000WO2000006556A1 Substituted oxazolines as antiproliferative agents
02/10/2000WO2000006531A2 Nitric esters and nitrate salts of specific drugs
02/10/2000WO1999063939A3 Multibinding inhibitors of cyclooxygenase-2
02/10/2000CA2339071A1 Substituted pyrazole derivatives condensed with six-membered heterocyclic rings
02/09/2000EP0977725A1 New fatty acid derivatives
02/09/2000CN1243831A Preparation of cyclopropane derivatives with anti-virus effectiveness and intermediate therefor
02/08/2000CA2006387C Xanthine derivatives with adenosine-antagonistic activity
02/03/2000WO2000005234A1 NF-λB INHIBITORS CONTAINING INDAN DERIVATIVES AS THE ACTIVE INGREDIENT
02/03/2000WO1999063929A3 Multibinding inhibitors of microsomal triglyceride transferase protein
02/03/2000WO1999057120A9 Novel serotonin-like 9-substituted hypoxanthine and methods of use
02/03/2000WO1999050251A3 Cyclin dependent kinase inhibitors
1 ... 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 ... 120